Trifon Chervenkov

883 total citations
24 papers, 706 citations indexed

About

Trifon Chervenkov is a scholar working on Molecular Biology, Epidemiology and Hematology. According to data from OpenAlex, Trifon Chervenkov has authored 24 papers receiving a total of 706 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Epidemiology and 3 papers in Hematology. Recurrent topics in Trifon Chervenkov's work include Phytochemicals and Antioxidant Activities (3 papers), Sperm and Testicular Function (2 papers) and Neuroinflammation and Neurodegeneration Mechanisms (2 papers). Trifon Chervenkov is often cited by papers focused on Phytochemicals and Antioxidant Activities (3 papers), Sperm and Testicular Function (2 papers) and Neuroinflammation and Neurodegeneration Mechanisms (2 papers). Trifon Chervenkov collaborates with scholars based in Bulgaria, Austria and Japan. Trifon Chervenkov's co-authors include Daniela Gerova, T. Yankova, Diana Ivanova, Bistra Galunska, Nikolay Conev, Assia Konsoulova, Ivan Donev, Rouzha Pancheva, Anton B. Tonchev and Stoyan Pavlov and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Ethnopharmacology and Journal of Neuroimmunology.

In The Last Decade

Trifon Chervenkov

21 papers receiving 624 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Trifon Chervenkov Bulgaria 6 304 290 216 182 102 24 706
Agnieszka Bazylko Poland 19 303 1.0× 351 1.2× 235 1.1× 267 1.5× 112 1.1× 41 788
Daniela Gerova Bulgaria 7 303 1.0× 287 1.0× 217 1.0× 146 0.8× 104 1.0× 19 668
Ahmet Doğan Türkiye 15 168 0.6× 335 1.2× 280 1.3× 185 1.0× 92 0.9× 44 604
D Grochowski Poland 10 291 1.0× 244 0.8× 186 0.9× 205 1.1× 71 0.7× 26 689
İsmail Şenkardeş Türkiye 18 259 0.9× 407 1.4× 343 1.6× 253 1.4× 129 1.3× 59 823
Mona M. Marzouk Egypt 17 206 0.7× 357 1.2× 228 1.1× 312 1.7× 92 0.9× 57 725
Parisa Sarkhail Iran 16 131 0.4× 367 1.3× 201 0.9× 240 1.3× 106 1.0× 36 672
Salwa A. Kawashty Egypt 17 194 0.6× 361 1.2× 204 0.9× 327 1.8× 82 0.8× 41 680
Abdullah Dalar Türkiye 16 271 0.9× 334 1.2× 218 1.0× 196 1.1× 116 1.1× 36 734
Haji Akber Aisa China 17 178 0.6× 294 1.0× 188 0.9× 435 2.4× 81 0.8× 48 781

Countries citing papers authored by Trifon Chervenkov

Since Specialization
Citations

This map shows the geographic impact of Trifon Chervenkov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Trifon Chervenkov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Trifon Chervenkov more than expected).

Fields of papers citing papers by Trifon Chervenkov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Trifon Chervenkov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Trifon Chervenkov. The network helps show where Trifon Chervenkov may publish in the future.

Co-authorship network of co-authors of Trifon Chervenkov

This figure shows the co-authorship network connecting the top 25 collaborators of Trifon Chervenkov. A scholar is included among the top collaborators of Trifon Chervenkov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Trifon Chervenkov. Trifon Chervenkov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Petrov, Petar, et al.. (2025). PTM-Fetuin-A: A Novel Biomarker for Early Detection of Diabetic Kidney Disease. 9(1). 13–19. 1 indexed citations
2.
Chervenkov, Trifon, et al.. (2023). Genus-Level Analysis of Gut Microbiota in Children with Autism Spectrum Disorder: A Mini Review. Children. 10(7). 1103–1103. 6 indexed citations
3.
Chervenkov, Trifon, et al.. (2023). MLPA in the initial genetic screening of patients with acute myeloid leukemia. Romanian Journal of Internal Medicine. 62(1). 44–51.
4.
Chervenkov, Trifon, et al.. (2023). Oxford Nanopore Technology and its Application in Liquid Biopsies. Current Genomics. 24(6). 337–344. 4 indexed citations
5.
Kisheva, Аntoniya, et al.. (2021). Galectin-3 in patients with atrial fibrillation and restored sinus rhythm. SHILAP Revista de lepidopterología. 63(3). 329–336. 2 indexed citations
6.
Chervenkov, Trifon, et al.. (2020). Association between polymorphic markers human leucocyte antigen-G and tumour necrosis factor alpha and susceptibility to recurrent miscarriages among Bulgarian women. Journal of Turkish Society of Obstetric and Gynecology. 17(1). 34–39. 2 indexed citations
7.
Chervenkov, Trifon, et al.. (2020). The association of gr/gr deletion in the Y chromosome and impaired spermatogenesis in Bulgarian males: a pilot study. Middle East Fertility Society Journal. 25(1). 3 indexed citations
8.
Pavlov, Stoyan, et al.. (2020). Composite hydrogels and their application for 3D Bioprinting in the Regenerative medicine. 367. 25–28. 2 indexed citations
9.
Miteva, Darina, et al.. (2017). PROGNOSTIC VALUE OF PRO-ADRENOMEDULLIN, PROCALCITONIN AND C-REACTIVE PROTEIN IN COMMUNITY ACQUIRED PNEUMONIA. CBU International Conference Proceedings. 5. 978–982. 1 indexed citations
10.
Chervenkov, Trifon, et al.. (2016). CHRONIC MYELOMONOCYTIC LEUKEMIA - REVIEW AND CLINICAL EXPERIENCE OF THE HEMATOLOGY DEPARTMENT UMHAT "ST. MARINA" - VARNA. Journal of IMAB - Annual Proceeding (Scientific Papers). 22(1). 1091–1095.
11.
Gerova, Daniela, et al.. (2016). Serum level of the human antimicrobial cathelicidin (hCAP18/LL-37) in patients with psoriasis vulgaris. Scripta Scientifica Medica. 48(2). 37–37. 1 indexed citations
12.
Galunska, Bistra, et al.. (2015). Experimental models of metabolic syndrome in rats. Scripta Scientifica Medica. 47(2). 14–14. 33 indexed citations
14.
Chervenkov, Trifon, et al.. (2013). Expression and differential response to haloperidol treatment of Cyclon/CCDC86 mRNA in schizophrenia patients. Neurochemistry International. 62(6). 870–872. 3 indexed citations
15.
Chervenkov, Trifon, et al.. (2013). Expression of Cyclon/CCDC86, a novel nuclear protein, in the hippocampus of adult non-human primates. Journal of Neuroimmunology. 258(1-2). 96–99. 2 indexed citations
16.
Atanassova, Miroslava, et al.. (2013). Baseline viral load - a predictor of treatment response in advanced hepatitis C. Scripta Scientifica Medica. 45(3). 53–53. 1 indexed citations
17.
Chervenkov, Trifon. (2012). ASPECTS OF CYCLON AND BDNF GENE EXPRESSION IN SCHIZOPHRENIA PATIENTS. SHILAP Revista de lepidopterología. 18, 3(2012). 276–279. 2 indexed citations
18.
Ivanova, Diana, et al.. (2006). Correlation between the In Vitro antioxidant activity and polyphenol content of aqueous extracts from bulgarian herbs. Phytotherapy Research. 20(11). 961–965. 206 indexed citations
19.
Ivanova, Donika, et al.. (2005). ANTIOXIDATIVE POTENTIAL OF EDIBLE WILD BULGARIAN FRUITS. 4 indexed citations
20.
Ivanova, Diana, Daniela Gerova, Trifon Chervenkov, & T. Yankova. (2004). Polyphenols and antioxidant capacity of Bulgarian medicinal plants. Journal of Ethnopharmacology. 96(1-2). 145–150. 387 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026